KAAACI Allergic Rhinitis Guidelines: Part 2. Update in Non-pharmacological Management

Allergic rhinitis is the most common chronic disease worldwide. Various upper airway symptoms lower quality of life, and due to the recurrent symptoms, multiple treatments are usually attempted rather than one definitive treatment. There are alternatives to medical (medication-based) and non-medical...

Full description

Saved in:
Bibliographic Details
Published in:Allergy, asthma & immunology research asthma & immunology research, 2023-03, Vol.15 (2), p.145-159
Main Authors: Park, Do-Yang, Lee, Yong Ju, Kim, Dong-Kyu, Kim, Soo Whan, Yang, Hyeon-Jong, Kim, Do Hyun, Jun, Young Joon, Park, Sang Chul, Kim, Bong-Seong, Yang, Song-I, Lee, Il Hwan, Kim, Minji, Ryu, Gwanghui, Kang, Sung-Yoon, Kim, Mi-Ae, Lee, Sang Min, Kim, Hyun-Jung, Choi, Gil-Soon, Chung, Soo Jie, Lee, Hyun Jong, Kim, Hyo-Bin, Choi, Jeong-Hee
Format: Article
Language:English
Subjects:
Allergens
Allergic rhinitis
Drug therapy
Environmental management
Guidelines
Hay fever
Health services
Immunotherapy
Medical treatment
Nose
Oral administration
Pharmacology
Quality of life
Respiratory tract diseases
Review
Rhinitis
Signs and symptoms
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Allergic rhinitis is the most common chronic disease worldwide. Various upper airway symptoms lower quality of life, and due to the recurrent symptoms, multiple treatments are usually attempted rather than one definitive treatment. There are alternatives to medical (medication-based) and non-medical treatments. A guideline is needed to understand allergic rhinitis and develop an appropriate treatment plan. We have developed guidelines for medical treatment based on previous reports. The current guidelines herein are associated with the "KAAACI Evidence-Based Guidelines for Allergic Rhinitis in Korea, Part 1: Update in pharmacotherapy" in which we aimed to provide evidence-based recommendations for the medical treatment of allergic rhinitis. Part 2 focuses on non-pharmacological management, including allergen-specific immunotherapy, subcutaneous or sublingual immunotherapy, nasal saline irrigation, environmental management strategies, companion animal management, and nasal turbinate surgery. The evidence to support the treatment efficacy, safety, and selection has been systematically reviewed. However, larger controlled studies are needed to elevate the level of evidence to select rational non-medical therapeutic options for patients with allergic rhinitis.
ISSN:2092-7355
2092-7363
DOI:10.4168/aair.2023.15.2.145